GOVX

#5173
GeoVax Labs, Inc. New
1.2400 USD
+0.81%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
1.2400
1.2400
Year Range
1.1368
1.9900
Daily Change
+0.81%
Monthly Change
-26.63%
6 month change
-14.48%
Year Change
-14.48%
Previous Close
1.2300
Open
1.2400
Bid
Ask
Low
1.2400
High
1.2400
Volume
4
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 3.5868 M
  • Employee 17
  • Founded 1988
  • CEO David A. Dodd
  • Website www.geovax.com
  • Headquarter Delaware, United States
  • FIGI BBG000BGGJD8
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.19
Price to sales ratio
1.65

GeoVax Labs Inc

GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated.

News